A Phase 1, Single-Dose, Open-Label, Crossover Study To Assess The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 06 Sep 2011
At a glance
- Drugs Ciclosporin; PF 4991532
- Indications Heart transplant rejection; Liver transplant rejection; Psoriasis; Renal transplant rejection; Rheumatoid arthritis; Transplant rejection; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 06 Sep 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2011 New trial record